Clinical significance of genome-wide minimally deleted regions in oral squamous cell carcinomas

Genes Chromosomes and Cancer

Volumn 50, Issue 5, 2011, Pages 358-369

  Chien, Huei Tzu ^a   Liao, Chun Ta ^b   Huang, Shiang Fu ^b   Chen, I How ^b   Liu, Tsung Yun ^c   Jou, Yuh Shan ^d   Wang, Hung Ming ^b   Hsieh, Ling Ling ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ADULT; ALLELE; ARTICLE; CANCER PATIENT; CARCINOGENESIS; CHROMOSOME 11Q; CHROMOSOME 14Q; CHROMOSOME 7Q; CHROMOSOME LOSS; CIGARETTE SMOKING; DISEASE FREE SURVIVAL; DNA EXTRACTION; FEMALE; GENE DELETION; HETEROZYGOSITY LOSS; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; MOUTH CARCINOMA; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; SQUAMOUS CELL CARCINOMA; TAIWAN;

ALLELES; ALLELIC IMBALANCE; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; DNA, NEOPLASM; GENE DELETION; GENOME; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MOUTH NEOPLASMS; PROGNOSIS; SMOKING; TAIWAN; TUMOR MARKERS, BIOLOGICAL;

EID: 79952376349     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20861     Document Type: Article

References (49)

1. Alimov A, Sundelin B, Wang N, Larsson C, Bergerheim U. 2004. Loss of 14q31-q32.2 in renal cell carcinoma is associated with high malignancy grade and poor survival. Int J Oncol 25: 179-185.
2. Allinen M, Peri L, Kujala S, Lahti-Domenici J, Outila K, Karppinen SM, Launonen V, Winqvist R. 2002. Analysis of 11q21-24 loss of heterozygosity candidate target genes in breast cancer: Indications of TSLC1 promoter hypermethylation. Genes Chromosomes Cancer 34: 384-389.
3. Ando K, Ohira M, Ozaki T, Nakagawa A, Akazawa K, Suenaga Y, Nakamura Y, Koda T, Kamijo T, Murakami Y, Nakagawara A. 2008. Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation. Int J Cancer 123: 2087-2094.
4. Associations of Directors of Anatomic and Surgical Pathology (ADASP). 2000. Recommendations for the reporting of specimens containing oral cavity and oropharynx neoplasms. Mod Pathol 13: 1038-1041.
5. Beder LB, Gunduz M, Ouchida M, Fukushima K, Gunduz E, Ito S, Sakai A, Nagai N, Nishizaki K, Shimizu K. 2003. Genome-wide analyses on loss of heterozygosity in head and neck squamous cell carcinomas. Lab Invest 83: 99-105.
6. Bicher A, Ault K, Kimmelman A, Gershenson D, Reed E, Liang B. 1997. Loss of heterozygosity in human ovarian cancer on chromosome 19q. Gynecol Oncol 66: 36-40.
7. Bisgaard ML, Jager AC, Dalgaard P, Sondergaard JO, Rehfeld JF, Nielsen FC. 2001. Allelic loss of chromosome 2p21-16.3 is associated with reduced survival in sporadic colorectal cancer. Scand J Gastroenterol 36: 405-409.
8. Bohm M, Kleine-Besten R, Wieland I. 2000. Loss of heterozygosity analysis on chromosome 5p defines 5p13-12 as the critical region involved in tumor progression of bladder carcinomas. Int J Cancer 89: 194-197.
9. Chang JT, Wang HM, Chang KW, Chen WH, Wen MC, Hsu YM, Yung BY, Chen IH, Liao CT, Hsieh LL, Cheng AJ. 2005. Identification of differentially expressed genes in oral squamous cell carcinoma (OSCC): Overexpression of NPM, CDK1 and NDRG1 and underexpression of CHES1. Int J Cancer 114: 942-949.
10. Chen Y, Chen C. 2008. DNA copy number variation and loss of heterozygosity in relation to recurrence of and survival from head and neck squamous cell carcinoma: A review. Head Neck 30: 1361-1383.
11. Cheng A, Schmidt BL. 2008. Management of the N0 neck in oral squamous cell carcinoma. Oral Maxillofac Surg Clin North Am 20: 477-497.
12. Cui Y, Ying Y, van Hasselt A, Ng KM, Yu J, Zhang Q, Jin J, Liu D, Rhim JS, Rha SY, Loyo M, Chan AT, Srivastava G, Tsao GS, Sellar GC, Sung JJ, Sidransky D, Tao Q. 2008. OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation. PLoS One 3: e2990.
13. De Schutter H, Spaepen M, Mc Bride WH, Nuyts S. 2007. The clinical relevance of microsatellite alterations in head and neck squamous cell carcinoma: A critical review. Eur J Hum Genet 15: 734-741.
14. Department of Health. 2009. Cancer Registry Annual Report 2006. Taipei, Taiwan: Bureau of Health Promotion, Department of Health.
15. Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J, Seboun E, Lathrop M, Gyapay G, Morissette J, Weissenbach J. 1996. A comprehensive genetic map of the human genome based on 5, 264 microsatellites. Nature 380: 152-154.
16. Fox BP, Kandpal RP. 2009. EphB6 receptor significantly alters invasiveness and other phenotypic characteristics of human breast carcinoma cells. Oncogene 28: 1706-1713.
17. Girard L, Zochbauer-Muller S, Virmani AK, Gazdar AF, Minna JD. 2000. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res 60: 4894-4906.
18. Glavac D, Volavsek M, Potocnik U, Ravnik-Glavac M, Gale N. 2003. Low microsatellite instability and high loss of heterozygosity rates indicate dominant role of the suppressor pathway in squamous cell carcinoma of head and neck and loss of heterozygosity of 11q14.3 correlates with tumor grade. Cancer Genet Cytogenet 146: 27-32.
19. Grati FR, Sirchia SM, Garagiola I, Sironi E, Galioto S, Rossella F, Serafini P, Dulcetti F, Bozzetti A, Brusati R, Simoni G. 2000. Losses of heterozygosity in oral and oropharyngeal epithelial carcinomas. Cancer Genet Cytogenet 118: 57-61.
20. Haddad RI, Shin DM. 2008. Recent advances in head and neck cancer. N Engl J Med 359: 1143-1154.
21. Hoque MO, Lee CC, Cairns P, Schoenberg M, Sidransky D. 2003. Genome-wide genetic characterization of bladder cancer: A comparison of high-density single-nucleotide polymorphism arrays and PCR-based microsatellite analysis. Cancer Res 63: 2216-2222.
22. Jou YS, Lee CS, Chang YH, Hsiao CF, Chen CF, Chao CC, Wu LS, Yeh SH, Chen DS, Chen PJ. 2004. Clustering of minimal deleted regions reveals distinct genetic pathways of human hepatocellular carcinoma. Cancer Res 64: 3030-3036.
23. Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC. 1995. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med 24: 450-453.
24. Kozlowski L, Filipowski T, Rucinska M, Pepinski W, Janica J, Skawronska M, Poznanski J, Wojtukiewicz MZ. 2006. Loss of heterozygosity on chromosomes 2p, 3p, 18q21.3 and 11p15.5 as a poor prognostic factor in stage II and III (FIGO) cervical cancer treated by radiotherapy. Neoplasma 53: 440-443.
25. Li G, Osborne J, Asiegbu FO. 2006. A macroarray expression analysis of novel cDNAs vital for growth initiation and primary metabolism during development of Heterobasidion parviporum conidiospores. Environ Microbiol 8: 1340-1350.
26. Li SP, Wang HY, Li JQ, Zhang CQ, Feng QS, Huang P, Yu XJ, Huang LX, Liang QW, Zeng YX. 2001. Genome-wide analyses on loss of heterozygosity in hepatocellular carcinoma in Southern China. J Hepatol 34: 840-849.
27. Lin YC, Hsiao JR, Tsai ST. 2004. Salvage surgery as the primary treatment for recurrent oral squamous cell carcinoma. Oral Oncol 40: 183-189.
28. Markowski J, Tyszkiewicz T, Jarzab M, Oczko-Wojciechowska M, Gierek T, Witkowska M, Paluch J, Kowalska M, Wygoda Z, Lange D, Jarzab B. 2009. Metal-proteinase ADAM12, kinesin 14 and checkpoint suppressor 1 as new molecular markers of laryngeal carcinoma. Eur Arch Otorhinolaryngol 266: 1501-1507.
29. Massano J, Regateiro FS, Januario G, Ferreira A. 2006. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102: 67-76.
30. Matise TC, Chen F, Chen W, De La Vega FM, Hansen M, He C, Hyland FC, Kennedy GC, Kong X, Murray SS, Ziegle JS, Stewart WC, Buyske S. 2007. A second-generation combined linkage physical map of the human genome. Genome Res 17: 1783-1786.
31. Parikh RA, White JS, Huang X, Schoppy DW, Baysal BE, Baskaran R, Bakkenist CJ, Saunders WS, Hsu LC, Romkes M, Gollin SM. 2007. Loss of distal 11q is associated with DNA repair deficiency and reduced sensitivity to ionizing radiation in head and neck squamous cell carcinoma. Genes Chromosomes Cancer 46: 761-775.
32. Pehlivan D, Gunduz E, Gunduz M, Nagatsuka H, Beder LB, Cengiz B, Rivera RS, Fukushima K, Palanduz S, Ozturk S, Yamanaka N, Shimizu K. 2008. Loss of heterozygosity at chromosome 14q is associated with poor prognosis in head and neck squamous cell carcinomas. J Cancer Res Clin Oncol 134: 1267-1276.
33. Poli-Frederico RC, Bergamo NA, Reis PP, Kowalski LP, Zielenska M, Squire JA, Rogatto SR. 2000. Chromosome 22q a frequent site of allele loss in head and neck carcinoma. Head Neck 22: 585-590.
34. Qiu W, Schonleben F, Thaker HM, Goggins M, Su GH. 2006. A novel mutation of STK11/LKB1 gene leads to the loss of cell growth inhibition in head and neck squamous cell carcinoma. Oncogene 25: 2937-2942.
35. Rutherford S, Yu Y, Rumpel CA, Frierson HF, Jr., Moskaluk CA. 2006. Chromosome 6 deletion and candidate tumor suppressor genes in adenoid cystic carcinoma. Cancer Lett 236: 309-317.
36. Shin JH, Kang SM, Kim YS, Shin DH, Chang J, Kim SK. 2005. Identification of tumor suppressor loci on the long arm of chromosome 5 in pulmonary large cell neuroendocrine carcinoma. Chest 128: 2999-3003.
37. Singh LS, Berk M, Oates R, Zhao Z, Tan H, Jiang Y, Zhou A, Kirmani K, Steinmetz R, Lindner D, Xu Y. 2007. Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer. J Natl Cancer Inst 99: 1313-1327.
38. Staub E, Grone J, Mennerich D, Ropcke S, Klamann I, Hinzmann B, Castanos-Velez E, Mann B, Pilarsky C, Brummendorf T, Weber B, Buhr HJ, Rosenthal A. 2006. A genome-wide map of aberrantly expressed chromosomal islands in colorectal cancer. Mol Cancer 5: 37.
39. Takebayashi S, Hickson A, Ogawa T, Jung KY, Mineta H, Ueda Y, Grenman R, Fisher SG, Carey TE. 2004. Loss of chromosome arm 18q with tumor progression in head and neck squamous cancer. Genes Chromosomes Cancer 41: 145-154.
40. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL, Massague J. 2008. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451: 147-152.
41. Thomas SJ, MacLennan R. 1992. Slaked lime and betel nut cancer in Papua New Guinea. Lancet 340: 577-578.
42. Tsantoulis PK, Kastrinakis NG, Tourvas AD, Laskaris G, Gorgoulis VG. 2007. Advances in the biology of oral cancer. Oral Oncol 43: 523-534.
43. Ulivieri A, Lavra L, Dominici R, Giacomelli L, Brunetti E, Sciacca L, Trovato M, Barresi G, Foukakis T, Jia-Jing L, Larsson C, Bartolazzi A, Sciacchitano S. 2008. Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness. J Pathol 215: 87-96.
44. Viloria CG, Obaya AJ, Moncada-Pazos A, Llamazares M, Astudillo A, Capella G, Cal S, Lopez-Otin C. 2009. Genetic inactivation of ADAMTS15 metalloprotease in human colorectal cancer. Cancer Res 69: 4926-4934.
45. Wang G, Mao W, Zheng S. 2008. MicroRNA-183 regulates Ezrin expression in lung cancer cells. FEBS Lett 582: 3663-3668.
46. Weber F, Xu Y, Zhang L, Patocs A, Shen L, Platzer P, Eng C. 2007. Microenvironmental genomic alterations and clinicopathological behavior in head and neck squamous cell carcinoma. J Am Med Assoc 297: 187-195.
47. Xu SF, Peng ZH, Li DP, Qiu GQ, Zhang F. 2003. Refinement of heterozygosity loss on chromosome 5p15 in sporadic colorectal cancer. World J Gastroenterol 9: 1713-1718.
48. Yeo M, Park HJ, Kim DK, Kim YB, Cheong JY, Lee KJ, Cho SW. 2010. Loss of SM22 is a characteristic signature of colon carcinogenesis and its restoration suppresses colon tumorigenicity in vivo and in vitro. Cancer 116: 2581-2589.
49. Yu J, Bulk E, Ji P, Hascher A, Tang M, Metzger R, Marra A, Serve H, Berdel WE, Wiewroth R, Koschmieder S, Muller-Tidow C. 2010. The EPHB6 receptor tyrosine kinase is a metastasis suppressor that is frequently silenced by promoter DNA hypermethylation in non-small cell lung cancer. Clin Cancer Res 16: 2275-2283.